Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization

PURPOSE: To determine the pre-treatment ocular factors significantly associated with the visual outcome 24 months after intravitreal bevacizumab (IVB) for myopic choroidal neovascularization (mCNV). METHODS: A total of 23 eyes of 23 patients with mCNV were treated with IVB followed by as needed ther...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Nakanishi, H, Tsujikawa, A, Yodoi, Y, Ojima, Y, Otani, A, Tamura, H, Yamashiro, K, Ooto, S, Yoshimura, N
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2011
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3178312/
https://ncbi.nlm.nih.gov/pubmed/21252956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2010.226
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы